InvestorsHub Logo
icon url

slbrown

08/25/10 2:49 PM

#6741 RE: Cobraman #6730

Miniscule??? Well tell that to the Pfizer, J&J, Lily, Roche, etc. and they will laugh at you all the way to the bank!

Now for educational purposes I will explain how this works:
The rep will engage the physician and explain the benefits vs the current pain relievers, which is a huge issue right now and the physicians are going to be all ears, because many of them are under scrutiny for over prescribing pain meds that are addictive and down right dangerous. Every physician out there is also well aware of the situation regarding acetomenophen and other OTC pain meds that are more harmful than good for their patients. This is a huge hot button and when given a logical alternative they will bypass the system to suit their patient needs without blinking an eye.

I have been a pharmaceutical rep for P&G for many years and I DO understand this business and this is why I am so enthused what NPHC is bringing to market. Nyloxin RX will be great alternatives for physicians to use for their patients and I believe Henry Schein will also carry Nyloxin and Nyloxin ES, but I am not completely sure of that yet, but if they do it would absolutely no problem to recommend the patient to go to the pharmacy and pick it up.

The issue is about who knows what is going on and does there due diligence correctly!
icon url

cngreen

08/26/10 1:06 PM

#6789 RE: Cobraman #6730

I again disagree with you cobraman. Henry schein will be educating doctors on nyloxin. Doctors are in fact looking to get people off narcotic drugs. Don't you read the news about the FDA and Tylenol??